Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3498)
All Articles published online
|
Mar 15, 2004 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu HP, Feng GS, Liang HM, Zheng CS, Li X. Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats. World J Gastroenterol 2004; 10(6): 813-818 [PMID: 15040023 DOI: 10.3748/wjg.v10.i6.813] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i6/813.htm |
| Number | Citing Articles |
| 1 |
Yongjie Huang, Tiansi Wang, Jiefen Yang, Xin Wu, Wei Fan, Jianming Chen. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review. International Journal of Nanomedicine 2022; : 2335 doi: 10.2147/IJN.S363456
|
| 2 |
Bao T. Le, Prithi Raguraman, Tamer R. Kosbar, Susan Fletcher, Steve D. Wilton, Rakesh N. Veedu. Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics. Molecular Therapy - Nucleic Acids 2019; 14: 142 doi: 10.1016/j.omtn.2018.11.007
|
| 3 |
Sun Hwa Kim, Soo Hyeon Lee, Huayu Tian, Xuesi Chen, Tae Gwan Park. Prostate cancer cell–specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes. Journal of Drug Targeting 2009; 17(4): 311 doi: 10.1080/10611860902767232
|
| 4 |
Hongxin Cai, Xiaoyue Du, Yufeng Deng, Dejian Cao, Lele Wang, Zhiguo Wu, Xianchao Zhang, Jinbiao Xu, Baogang Xie. Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats. Bioanalysis 2024; 16(10): 461 doi: 10.4155/bio-2023-0215
|
| 5 |
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases. 2010; : 421 doi: 10.1007/978-3-642-00150-5_28
|
| 6 |
Roberta Pang, Ronnie T.P. Poon. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Letters 2006; 242(2): 151 doi: 10.1016/j.canlet.2006.01.008
|
| 7 |
David Semela, Jean-François Dufour. Angiogenesis and hepatocellular carcinoma. Journal of Hepatology 2004; 41(5): 864 doi: 10.1016/j.jhep.2004.09.006
|
| 8 |
Ching-Chiu Liu, Zan Shen, Hsiang-Fu Kung, Marie CM Lin. Cancer gene therapy targeting angiogenesis: An updated Review. World Journal of Gastroenterology 2006; 12(43): 6941-6948 doi: 10.3748/wjg.v12.i43.6941
|
| 9 |
SABINE KRAUSE, YVONNE FÖRSTER, KAI KRAEMER, SUSANNE FUESSEL, MATTHIAS KOTZSCH, UTA SCHMIDT, MANFRED P. WIRTH, AXEL MEYE, BERND SCHWENZER. VASCULAR ENDOTHELIAL GROWTH FACTOR ANTISENSE PRETREATMENT OF BLADDER CANCER CELLS SIGNIFICANTLY ENHANCES THE CYTOTOXICITY OF MITOMYCIN C, GEMCITABINE AND CISPLATIN. Journal of Urology 2005; 174(1): 328 doi: 10.1097/01.ju.0000161588.94827.27
|
| 10 |
E. Jubeli, N. Yagoubi, F. Pascale, L. Bédouet, K. Slimani, D. Labarre, J.P. Saint-Maurice, A. Laurent, L. Moine. Embolization biomaterial reinforced with nanotechnology for an in-situ release of anti-angiogenic agent in the treatment of hyper-vascularized tumors and arteriovenous malformations. European Journal of Pharmaceutics and Biopharmaceutics 2015; 96: 396 doi: 10.1016/j.ejpb.2015.09.006
|
| 11 |
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases. 2005; : 91 doi: 10.1007/3-540-27194-5_8
|
| 12 |
Anand C. Annan, Paul B. Fisher, Paul Dent, Gene P. Siegal, David T. Curiel. The Molecular Basis of Human Cancer. 2017; : 811 doi: 10.1007/978-1-59745-458-2_42
|
| 13 |
Md. Emranul Karim, Kyi Kyi Tha, Iekhsan Othman, Mohammad Borhan Uddin, Ezharul Hoque Chowdhury. Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers. Pharmaceutics 2018; 10(2): 65 doi: 10.3390/pharmaceutics10020065
|
| 14 |
Junning Zhang, Dinglu Peng, Wei Qin, Weizhi Qi, Xiaoya Liu, Yucheng Luo, Qiongyu Guo, Lei Xi. Organ‐PAM: Photoacoustic Microscopy of Whole‐organ Multiset Vessel Systems. Laser & Photonics Reviews 2023; 17(7) doi: 10.1002/lpor.202201031
|
| 15 |
Xinting Pan, Weihua Sheng, Qingyun Zhu, Yufeng Xie, Zhenmin Ye, Jim Xiang, Dechun Li, Jicheng Yang. Inhibition of Pancreatic Carcinoma Growth by Adenovirus-Mediated Human Interleukin-24 Expression in Animal Model. Cancer Biotherapy and Radiopharmaceuticals 2008; 23(4): 425 doi: 10.1089/cbr.2008.0461
|
| 16 |
Xiong‐Zhi Wu, Guang‐Ru Xie, Dan Chen. Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2007; 22(8): 1178 doi: 10.1111/j.1440-1746.2007.04997.x
|
| 17 |
Bin Liang, ChuanSheng Zheng, GanSheng Feng, HanPing Wu, Yong Wang, Hui Zhao, Xin Li, Jun Qian, HuiMin Liang. Experimental Evaluation of Inhibitory Effect of 10-Hydroxycamptothecin on Hypoxia-inducible Factor-1α Expression and Angiogenesis in Liver Tumors after Transcatheter Arterial Embolization. Journal of Vascular and Interventional Radiology 2010; 21(10): 1565 doi: 10.1016/j.jvir.2010.05.028
|
| 18 |
|
| 19 |
Ron C. Gaba, Regina M. Schwind, Sebastien Ballet. Mechanism of Action, Pharmacokinetics, Efficacy, and Safety of Transarterial Therapies Using Ethiodized Oil: Preclinical Review in Liver Cancer Models. Journal of Vascular and Interventional Radiology 2018; 29(3): 413 doi: 10.1016/j.jvir.2017.09.025
|
| 20 |
Sun Hwa Kim, Ji Hoon Jeong, Soo Hyeon Lee, Sung Wan Kim, Tae Gwan Park. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. Journal of Controlled Release 2008; 129(2): 107 doi: 10.1016/j.jconrel.2008.03.008
|
| 21 |
Zhen Fan Yang, Ronnie T.P. Poon. Vascular Changes in Hepatocellular Carcinoma. The Anatomical Record 2008; 291(6): 721 doi: 10.1002/ar.20668
|
| 22 |
Young Il Kim, Jin Wook Chung. Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery. Expert Review of Gastroenterology & Hepatology 2008; 2(6): 791 doi: 10.1586/17474124.2.6.791
|
| 23 |
Zhenmin Ye, Xiaohua Wang, Siguo Hao, Jiang Zhong, Jim Xiang, Jicheng Yang. Oncolytic Adenovirus-Mediated E1A Gene Therapy Induces Tumor-Cell Apoptosis and Reduces Tumor Angiogenesis Leading to Inhibition of Hepatocellular Carcinoma Growth in Animal Model. Cancer Biotherapy and Radiopharmaceuticals 2006; 21(3): 225 doi: 10.1089/cbr.2006.21.225
|
| 24 |
Gang Deng, Deng-Ling Zhao, Guang-Chao Li, Hui Yu, Gao-Jun Teng. Combination Therapy of Transcatheter Arterial Chemoembolization and Arterial Administration of Antiangiogenesis on VX2 Liver Tumor. CardioVascular and Interventional Radiology 2011; 34(4): 824 doi: 10.1007/s00270-011-0179-x
|